Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Can every patient be mobilized?
John F. Dipersio
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
Division of Oncology
Center of Regenerative Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Can every patient be mobilized?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Stem Cells
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
66%
CD34+ Cells
66%
Cell Yield
66%
Improved Outcomes
33%
Chemotherapy
33%
Granulocyte Colony-stimulating Factor (G-CSF)
33%
Hematopoietic Stem Cells
33%
Improved Survival
33%
Engraftment
33%
Cell Interaction
33%
CD34+
33%
Stem Cell Delivery
33%
New Agents
33%
Bone Marrow Microenvironment
33%
Plerixafor
33%
CXCR4 Inhibitor
33%
As(V)
33%
Minimum Threshold
33%
Stromal Stem Cells
33%
Immunology and Microbiology
Stem Cell
100%
CD34
60%
Hematopoietic Cell
20%
Hematopoietic Stem Cell Transplantation
20%
Engraftment
20%
Granulocyte Colony-Stimulating Factor
20%
Cell Interaction
20%
Plerixafor
20%
CXCR4
20%
Bone Marrow Microenvironment
20%
Medicine and Dentistry
Stem Cell
100%
Hematopoietic Stem Cell Transplantation
20%
Plerixafor
20%
Cell Interaction
20%
Engraftment
20%
Bone Marrow Microenvironment
20%
Granulocyte Colony Stimulating Factor
20%
Hematopoietic Cell
20%